Ticker

Theriva Biologics, Inc. (NYSEAMERICAN:TOVX - Get Free Report)'s stock price traded down 4.9% on Wednesday. The stock traded as low as $0.1926 and last traded at $0.2007. 2,809,196 shares were traded during trading, a decline of 74% from the average session volume of 10,784,255 shares. The stock had previously closed at $0.2110. Theriva Biologics

Theriva Biologics stock rose on Monday as it received positive Scientific Advice from CHMP for a Phase 3 trial of VCN-01 for PDAC treatment.

- EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC , including sample size, repeated dosing of VCN-01, and an adaptive design to potentially optimize trial timelines and outcomes -

Theriva Biologics, Inc. (NYSEAMERICAN:TOVX - Get Free Report)'s share price was up 5.2% during mid-day trading on Tuesday. The stock traded as high as $0.2187 and last traded at $0.2029. Approximately 6,389,528 shares changed hands during trading, an increase of 127% from the average daily volume of 2,820,571 shares. The stock had previously closed